Literature DB >> 20966694

Lifetime risk of undergoing surgery for pelvic organ prolapse.

Fiona J Smith1, C D'Arcy J Holman, Rachael E Moorin, Nicolas Tsokos.   

Abstract

OBJECTIVE: To investigate the lifetime risk of first-time incident pelvic organ prolapse (POP) surgery with the intention of updating previous risk estimates that have been based on members of managed-care populations.
METHODS: Age-specific incidence rates of first-time prolapse surgery between 1981 and 2005 were calculated based on 44,728-incident cases. We estimated the lifetime risk as the cumulative incidence to age 85 years based on a life-table method and using the most recent cross-sectional incidence rates for the period 2001-2005. Age-standardized rates by calendar year were also calculated to show the secular trend in prolapse surgery.
RESULTS: The lifetime risk of surgery for POP in the general female population was 19% based on the most recent cross-sectional rates, a figure higher than the 11-12% reported from U.S. managed-care populations.
CONCLUSION: There is a relatively high likelihood that a woman in Western Australia will undergo surgery for POP during her lifetime. If, as our results suggest, the burden of genital prolapse in general populations is higher than previously thought, there is justification for a stronger evidence base for prevention, early detection and intervention to reduce the personal and societal costs of these gynecological conditions. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2010        PMID: 20966694     DOI: 10.1097/AOG.0b013e3181f73729

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  191 in total

1.  "Mommy, how will the baby get out of your tummy? Will it hurt you?"

Authors:  John O L DeLancey
Journal:  Am J Obstet Gynecol       Date:  2017-08       Impact factor: 8.661

2.  Differences in recurrent prolapse at 1 year after total vs supracervical hysterectomy and robotic sacrocolpopexy.

Authors:  Erinn M Myers; Lauren Siff; Blake Osmundsen; Elizabeth Geller; Catherine A Matthews
Journal:  Int Urogynecol J       Date:  2014-11-01       Impact factor: 2.894

3.  Medium-term clinical outcomes following surgical repair for vaginal prolapse with tension-free mesh and vaginal support device.

Authors:  T Sayer; J Lim; J M Gauld; P Hinoul; P Jones; N Franco; D Van Drie; M Slack
Journal:  Int Urogynecol J       Date:  2011-12-06       Impact factor: 2.894

4.  Fibulin-5: two for the price of one maintaining pelvic support.

Authors:  Gina M Northington
Journal:  J Clin Invest       Date:  2011-04-25       Impact factor: 14.808

5.  Anterior and posterior compartment 3D endovaginal ultrasound anatomy based on direct histologic comparison.

Authors:  S Abbas Shobeiri; Dena White; Lieschen H Quiroz; Mikio A Nihira
Journal:  Int Urogynecol J       Date:  2012-03-09       Impact factor: 2.894

6.  Variables Affecting Intra-abdominal Pressure During Lifting in the Early Postpartum Period.

Authors:  Yvonne Hsu; Robert Hitchcock; Stefan Niederauer; Ingrid E Nygaard; Janet M Shaw; Xiaoming Sheng
Journal:  Female Pelvic Med Reconstr Surg       Date:  2018 Jul/Aug       Impact factor: 2.091

7.  Evaluation of extracellular matrix protein expression and apoptosis in the uterosacral ligaments of patients with or without pelvic organ prolapse.

Authors:  Ya-Pei Zhu; Ting Xie; Tao Guo; Zhi-Jing Sun; Lan Zhu; Jing-He Lang
Journal:  Int Urogynecol J       Date:  2020-07-31       Impact factor: 2.894

8.  Delivery mode and the risk of levator muscle avulsion: a meta-analysis.

Authors:  Talia Friedman; Guy D Eslick; Hans Peter Dietz
Journal:  Int Urogynecol J       Date:  2019-01-16       Impact factor: 2.894

9.  Does concomitant anterior/apical repair during midurethral sling improve the overactive bladder component of mixed incontinence?

Authors:  Alexis A Dieter; Autumn L Edenfield; Alison C Weidner; Pamela J Levin; Nazema Y Siddiqui
Journal:  Int Urogynecol J       Date:  2014-05-09       Impact factor: 2.894

10.  Pelvic floor muscle weakness: a risk factor for anterior vaginal wall prolapse recurrence.

Authors:  Jeffrey S Schachar; Hemikaa Devakumar; Laura Martin; Sara Farag; Eric A Hurtado; G Willy Davila
Journal:  Int Urogynecol J       Date:  2018-03-19       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.